The “Healthcare” practice at MarketsandMarkets is pleased to announce its “Analyst Briefing Presentation” on the “Drug Delivery Technology Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) – Global Forecasts to 2017”
http://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-1085.html
Drug delivery technologies alter the release of drug so as to facilitate optimum efficacy and safety.Such technologies simplify the dosing regimen and reduce side-effects, thus boosting patient compliance. The global drug delivery market is divided into nine segments, namely, oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable,andtransmucosal. Drug delivery technologies have grown phenomenally from plain drug reformulation and release technologies to innovative platforms that hold a huge potential for the effective delivery of biologicals and novel drugs.
The major drivers of this market are patent expiries of certain blockbuster drugs, growing demand for self administration and home healthcare devices, rising incidence of chronic diseases such as cardiovascular diseases, diabetes and cancer, growing focus on pediatric and geriatric patients, and advancing technology.However, drug failures and recalls, and technical barriers will hamper the growth of this market, to a certain extent.
The geographies covered in this study are North America, Europe, Asia, and Rest of the World (RoW). North America is the largest market for drug delivery, followed by Europe and Asia. North America and Europe are expected to grow at a slower pace, primarily due to a certain amount of saturation in the market. The Asian market is poised to register maximum growth over the next five years, owing to the expansion of the Asian economy, increase in disposable income, development of healthcare infrastructure, increasing penetration of health insurance, and rising prevalence of chronic diseases.
Research Methodology
Market Size
| Global Drug Delivery Technologies Market | |
| Global drug delivery technologies market | A bottom-up approach was used to calculate the total market.
Key data points were collected from public and paid secondary databases and successively validated by primary sources |
| Transdermal and Implantable | A bottom-up approach was used to calculate the total market for these segments. Key data points were collected from public and paid secondarydatabases and successively validated by primary sources |
| Oral, Pulmonary, Ocular, Nasal, Topical, Injectable, and Transmucosal | A top-down approach was used to calculate the total market for these segments. Key data points were collected from public and paid secondarydatabases and successively validated by primary sources |
Market share
| Global Drug Delivery Technologies Market | |
| Transdermal, Pulmonary, Injectable,
And Implantable |
Market share for key players has been discussed on the basis of secondary data available through paid and unpaid sources, analyzing product portfolios of major companies, and rating them on the basis of performance and quality. These data points were further validated through expert interviews. |
| Oral, Ocular, Nasal, Topical, and Transmucosal | Market share analysis for these segments has not been done as these markets are very fragmented. The data related to market share is not available from paid and unpaid secondary sources. |
Key Data Points from secondary sources
| Global Drug Delivery Technologies Market | |
| Transdermal, Pulmonary, Injectable,
And Implantable |
Market share for key players has been discussed on the basis of secondary data available through paid and unpaid sources, analyzing product portfolios of major companies, and rating them on the basis of performance and quality. These data points were further validated through expert interviews. |
| Oral, Ocular, Nasal, Topical, and Transmucosal | Market share analysis for these segments has not been done as these markets are very fragmented. The data related to market share is not available from paid and unpaid secondary sources. |
Assumptions
| Category | Description |
| Geographic Analysis | North America – 45% to 50%
Europe – 26% to 28% Asia – 12% to 15% RoW – 8% to 10%
Note: These percentages are assumed only for those segments where no data was available through public and paid secondary and primary sources.
|
Contact:
Mr. Rohan
North – Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
